Monarch Partners Asset Management LLC trimmed its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 28.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 404,810 shares of the health services provider’s stock after selling 162,090 shares during the period. Monarch Partners Asset Management LLC owned 0.30% of Select Medical worth $7,449,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. boosted its stake in Select Medical by 8.6% during the 2nd quarter. BlackRock Inc. now owns 15,243,922 shares of the health services provider’s stock valued at $276,678,000 after purchasing an additional 1,211,219 shares during the period. Victory Capital Management Inc. boosted its stake in Select Medical by 14.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,094,711 shares of the health services provider’s stock valued at $38,543,000 after purchasing an additional 270,498 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in Select Medical by 6.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,055,308 shares of the health services provider’s stock valued at $19,154,000 after purchasing an additional 65,091 shares during the period. Mesirow Financial Investment Management Equity Management acquired a new stake in shares of Select Medical in the 3rd quarter worth approximately $16,312,000. Finally, Principal Financial Group Inc. lifted its stake in shares of Select Medical by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 876,489 shares of the health services provider’s stock worth $15,119,000 after acquiring an additional 19,600 shares during the period. 75.08% of the stock is owned by hedge funds and other institutional investors.
In related news, insider David S. Chernow sold 41,202 shares of the stock in a transaction that occurred on Tuesday, August 7th. The shares were sold at an average price of $19.81, for a total transaction of $816,211.62. Following the completion of the sale, the insider now directly owns 891,455 shares of the company’s stock, valued at $17,659,723.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Chairman Robert A. Ortenzio sold 11,923 shares of the stock in a transaction that occurred on Thursday, August 30th. The shares were sold at an average price of $20.00, for a total transaction of $238,460.00. Following the sale, the chairman now directly owns 7,000,171 shares of the company’s stock, valued at $140,003,420. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 63,527 shares of company stock valued at $1,264,376. Company insiders own 19.86% of the company’s stock.
Shares of NYSE:SEM opened at $19.71 on Monday. The company has a market capitalization of $2.67 billion, a PE ratio of 20.32, a P/E/G ratio of 1.34 and a beta of 1.39. Select Medical Holdings Co. has a twelve month low of $15.83 and a twelve month high of $21.65. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 3.72.
Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, November 1st. The health services provider reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.28 billion. Select Medical had a net margin of 4.32% and a return on equity of 15.95%. The business’s revenue for the quarter was up 17.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.14 EPS. Equities analysts forecast that Select Medical Holdings Co. will post 1.05 earnings per share for the current year.
A number of analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of Select Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, August 7th. ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday. Finally, Credit Suisse Group assumed coverage on shares of Select Medical in a research note on Tuesday, October 16th. They issued a “neutral” rating and a $18.00 price target for the company. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $20.57.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Further Reading: Understanding Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.